Cell aging: when growth stimuli meet cell cycle arrest

Published Date: 08 Mar 2023

A new review article titled "Cellular Aging: When Growth Stimuli Meet Cell Cycle Arrest" is published in Aging.

Read Full News

Latest News

Three Psychiatric Emergencies Most Clinicians Misdiagnose

Delirium, alcohol and benzodiazepine withdrawal, and catatonia are often mistaken for psychiatric illness. Dr Adjoa Smalls-Mantey explains how to recognize them before they become life-threatening.

Risk of Second Primary Cancers After Early Breast Cancer

New data quantify the long-term risk of second cancers post-breast cancer. Dr Maurie Markman explores 20-year outcomes and the modest impact of prior systemic therapies.

Anemia Linked to Alzheimer’s Biomarkers, Dementia Risk

Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood biomarkers at highest risk.

Plant-Based Diet Quality May Affect Dementia Risk

A plant-based diet that includes whole grains, fruits, vegetables, and legumes is linked to a reduced risk for Alzheimer’s disease and related dementias, a new study shows.

Suboptimal UDCA Dosing Found in Primary Biliary Cholangitis

Nearly all patients with primary biliary cholangitis receive ursodeoxycholic acid, but a substantial proportion are prescribed suboptimal doses, a new Dutch study shows.

Has Your Care Been Compromised by VIP Syndrome?

Giving undue attention to an ‘important’ patient not only is unfair to others but also can negatively affect care.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Latest News

Delirium, alcohol and benzodiazepine withdrawal, and catatonia are often mistaken for psychiatric illness. Dr Adjoa Smalls-Mantey explains how to recognize them before they become life-threatening.

New data quantify the long-term risk of second cancers post-breast cancer. Dr Maurie Markman explores 20-year outcomes and the modest impact of prior systemic therapies.

Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood biomarkers at highest risk.

A plant-based diet that includes whole grains, fruits, vegetables, and legumes is linked to a reduced risk for Alzheimer’s disease and related dementias, a new study shows.

Nearly all patients with primary biliary cholangitis receive ursodeoxycholic acid, but a substantial proportion are prescribed suboptimal doses, a new Dutch study shows.

Giving undue attention to an ‘important’ patient not only is unfair to others but also can negatively affect care.

News All Time

How to Recognize Obsessive-Compulsive Disorder in Children

Dr Aron explains that screening tools and insight into the disorder can speed diagnosis of OCD.

The Rise of Zip-Code Immunity

With the CDC compromised by vaccine skeptics, states are being forced to build their own public health infrastructure.

When NPs and PAs Manage Cases Outside Their Specialty

Curbside consultations may take many forms, and there are significant benefits and risks involved.

NP Integration Boosts Osteoporosis Documentation

The integration of a nurse practitioner into the orthopedic inpatient workflow improves osteoporosis documentation substantially after hip fractures.

Researchers, Advocates Welcome EO on Psychedelics

The directive is expected to lead to fewer legal hurdles for psychedelic studies, increased funding, and potentially stepped-up rescheduling of the drugs.

NICE Backs New Second-Line Oral Option for CLL

NICE draft guidance recommends pirtobrutinib as an at-home oral option for CLL patients who have exhausted BTK inhibitor treatment.

Novel Copper-Binding Agent Shows Benefit in Wilson Disease

The novel drug ALXN1840 is both safe and effective in the treatment of adults with Wilson Disease, a rare disorder of copper overload, the phase 3 FOCUS trial suggests.

Targeting the Proximal Nerve: Faster Implant for Sleep Apnea

Hypoglossal nerve stimulation was approved in 2014 as a therapeutic alternative for obstructive sleep apnea.

Why Real Estate Is the One Investment Doctors Can’t Resist

Real estate is the number one income source outside of medicine for physicians. Here’s why so many doctors accept the risk, time demands, and costly surprises.

Data on Widespread Vaccine Skepticism May Be Misleading

Clinician’s careful read cautions against interpreting recent poll findings in isolation.

‘Remarkable’ Early Results for Novel Immune Therapy in SPS

A novel therapy improves mobility and could be the first approved therapy for stiff person syndrome.

When Caring Gets Complicated: Navigating Boundaries

How small, seemingly innocent decisions can blur professional boundaries — and put a doctor before the regulator.

Secondary Prevention of Ischemic Stroke

Dr Nina Lum discusses secondary prevention of ischemic stroke.

Fetal Growth Issue Tied to Preeclampsia in Moms With High BP

Women with chronic hypertension whose fetuses have lower estimated fetal weight and fetal growth restriction at 35-36 weeks’ gestation are more likely to develop superimposed preeclampsia.

Suspected LGA Diagnosis May Drive Obstetric Decisions

In a study of pregnant patients, suspected large for gestational age is associated with shifts in labor management, regardless of actual fetal size.

Cleveland Clinic Launches Respiratory Virus Dashboard in FL

The health system’s public, easily accessible data is an alternative to the state’s website, which can be challenging to use, sources say.

Recommended News For You

Detecting pancreatic cancer through changes in body composition and metabolism

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

Treating advanced prostate cancer

Metastatic breast cancer can be effectively treated with cyclical estrogen and anti-estrogen therapy.

Recommended Articles For You

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Single-dose radiation before surgery can eradicate breast cancer

2.

Never in a million years did I think I'd have to limit my chemotherapy.

3.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

4.

Virtual Reality Travel Reduces Cancer Pain.

5.

The Truth About Apple AirPods

1.

All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment

2.

A Comprehensive Guide To Understanding Plasma Osmolality

3.

The Rise of Immunotherapy: New Advances in Cancer Treatment

4.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

5.

Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

5.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot